Skip to content
10-Q

Quarterly Report

Surgery Partners, Inc. SGRY

0001638833-25-000092

← back to feed
Filed
May 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 5, 2025 128.16M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $229.3M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $269.5M
Stockholders Equity Q1 2025 · Mar 31, 2025 $1.74B
Stockholders Equity Q1 2025 · Dec 31, 2024 $1.79B
Current Liabilities Q1 2025 · Mar 31, 2025 $569.4M
Current Liabilities Q1 2025 · Dec 31, 2024 $624.4M
Current Assets Q1 2025 · Mar 31, 2025 $1.07B
Current Assets Q1 2025 · Dec 31, 2024 $1.12B
Total Assets Q1 2025 · Mar 31, 2025 $7.95B
Total Assets Q1 2025 · Dec 31, 2024 $7.89B
Shares Diluted Q1 2025 · Mar 31, 2024 125.97M sh
Capex Q1 2025 · Mar 31, 2024 $21M
Operating Cash Flow Q1 2025 · Mar 31, 2024 $40.7M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.10
Eps Basic Q1 2025 · Mar 31, 2024 −$0.10
Sga Expense Q1 2025 · Mar 31, 2024 $33.2M
Net Income Q1 2025 · Mar 31, 2024 −$12.4M
Operating Income Q1 2025 · Mar 31, 2024 $76M